Valneva

Valneva Launches 60M Euro Share Placement for Vaccine Development
Tip Ranks
Fri, 09/13/24 - 11:06 am
Valneva
funding
vaccines
chikungunya virus
Shigella
Zika virus
Valneva and Pfizer report positive data from trial of Lyme disease vaccine booster
Clinical Trials Arena
Tue, 09/3/24 - 11:25 am
Valneva
Pfizer
VLA15
clinical trials
vaccines
Lyme disease
Valneva gets $41m grant to roll out chikungunya vaccine
Pharmaphorum
Mon, 07/22/24 - 11:28 am
Valneva
funding
CEPI
vaccines
chikungunya virus
After coming up short in COVID, Valneva focuses on chikungunya vaccine launch
Fierce Pharma
Fri, 04/19/24 - 11:22 am
Valneva
vaccines
chikungunya virus
COVID-19
Valneva commences Phase I trial of second-generation Zika vaccine
Clinical Trials Arena
Wed, 03/27/24 - 11:05 am
Valneva
clinical trials
Zika virus
vaccines
VLA1601-102
CDC Advisory Panel Backs Valneva’s Chikungunya Vaccine for Certain Groups
BioSpace
Thu, 02/29/24 - 10:58 am
CDC
Valneva
vaccines
chikungunya virus
Valneva sells regulatory ‘fast pass’ for $103M
BioPharma Dive
Tue, 02/6/24 - 09:14 am
Valneva
FDA
fast pass
Ixchiq
Valneva reports latest findings from chikungunya vaccine trial
Clinical Trials Arena
Mon, 12/4/23 - 09:33 am
Valneva
chikungunya virus
Ixchiq
clinical trials
Valneva single-dose chikungunya vaccine poised to ‘revolutionize’ global health
Biopharma Reporter
Thu, 11/16/23 - 11:38 am
Valneva
vaccines
Ixchiq
FDA
chikungunya virus
FDA approves Valneva's chikungunya vaccine
Reuters
Thu, 11/9/23 - 11:39 pm
Valneva
vaccines
chikungunya virus
FDA
Ixchiq
FDA finds no misconduct at trial sites for Pfizer's Lyme disease shot, Care Access says
Reuters
Thu, 10/12/23 - 11:36 am
Pfizer
clinical trials
Lyme disease
Valneva
vaccines
FDA
Pfizer ticks off Lyme vaccine milestone, linking booster shot to pediatric antibody response
Fierce Biotech
Thu, 09/7/23 - 09:37 am
Pfizer
Lyme disease
vaccines
pediatric
clinical trials
VLA15
Valneva
Valneva reports data from chikungunya vaccine trial in adolescents
Clinical Trials Arena
Mon, 08/28/23 - 10:44 am
Valneva
clinical trials
VLS1553
chikungunya virus
FDA, seeking time for phase 4 talks, delays decision on Valneva's chikungunya vaccine by 3 months
Fierce Biotech
Mon, 08/14/23 - 10:13 am
Valneva
vaccines
FDA
chikungunya virus
Bavarian Nordic goes 2 for 2 in pivotal chikungunya vaccine trials, teeing up filing to rival Valneva
Fierce Biotech
Mon, 08/7/23 - 10:16 am
Bavarian Nordic
chikungunya virus
vaccine
clinical trials
Valneva
Bavarian Nordic bites back in chikungunya vaccine race, hitting phase 3 goal to stay on Valneva's heels
Fierce Biotech
Tue, 06/20/23 - 10:10 am
Bavarian Nordic
clinical trials
chikungunya virus
vaccines
Valneva
Valneva Reports Strong Phase III Chikungunya Vaccine Data After Merck’s Exit from Race
BioSpace
Tue, 06/13/23 - 11:27 am
Valneva
chikungunya virus
clinical trials
vaccines
Valneva, Pfizer push back timeline for Lyme disease vaccine
BioPharma Dive
Thu, 05/4/23 - 08:53 pm
Pfizer
Valneva
vaccines
Lyme disease
Major readouts on the horizon for small developers
EP Vantage
Fri, 03/31/23 - 10:19 am
Aldeyra Therapeutics
Autolus Therapeutics
Bavarian Nordic
BioXcel Therapeutics
Disc Medicine
Editas Medicine
Immunogen
Lantheus
Mersana Therapeutics
NGM Biopharmaceuticals
Omeros
Roche
Sutro BioPharma
uniQure
Valneva
Viking Therapeutics
Valneva, Pfizer delay end date of Lyme disease vaccine phase 3 trial to 2025
Seeking Alpha
Sun, 03/26/23 - 11:12 pm
Pfizer
Valneva
clinical trials
vaccines
Lyme disease
VLA15

Pages